These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Lim JS; Mietus-Snyder M; Valente A; Schwarz JM; Lustig RH Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):251-64. PubMed ID: 20368739 [TBL] [Abstract][Full Text] [Related]
23. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. Spahr L; Rubbia-Brandt L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. Valenti L; Dongiovanni P; Fargion S World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027 [TBL] [Abstract][Full Text] [Related]
25. Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis. Hellerbrand C Dig Dis; 2010; 28(6):783-91. PubMed ID: 21525763 [TBL] [Abstract][Full Text] [Related]
26. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Brown GT; Kleiner DE Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559 [TBL] [Abstract][Full Text] [Related]
27. Iron overload in nonalcoholic steatohepatitis. Fujita N; Takei Y Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026 [TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic fatty liver disease and the metabolic syndrome. Marchesini G; Babini M Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754 [TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease and the metabolic syndrome. Marchesini G; Marzocchi R; Agostini F; Bugianesi E Curr Opin Lipidol; 2005 Aug; 16(4):421-7. PubMed ID: 15990591 [TBL] [Abstract][Full Text] [Related]
30. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430 [TBL] [Abstract][Full Text] [Related]
34. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Bosserhoff A; Hellerbrand C Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008 [TBL] [Abstract][Full Text] [Related]
35. The impact of obesity on liver histology. Goodman ZD Clin Liver Dis; 2014 Feb; 18(1):33-40. PubMed ID: 24274863 [TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Asrih M; Jornayvaz FR Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480 [TBL] [Abstract][Full Text] [Related]
38. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Zhang X; Yang J; Guo Y; Ye H; Yu C; Xu C; Xu L; Wu S; Sun W; Wei H; Gao X; Zhu Y; Qian X; Jiang Y; Li Y; He F Hepatology; 2010 Apr; 51(4):1190-9. PubMed ID: 20162621 [TBL] [Abstract][Full Text] [Related]
39. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Syn WK; Teaberry V; Choi SS; Diehl AM Semin Liver Dis; 2009 May; 29(2):200-10. PubMed ID: 19387919 [TBL] [Abstract][Full Text] [Related]
40. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. Li ZZ; Berk M; McIntyre TM; Feldstein AE J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]